Company Analysis
Sign in

Armata Pharmaceuticals, Inc. (ARMP)

NYSE: ARMP · Biological Products, (No Diagnostic Substances) · Los Angeles, CA · filing with the SEC since 1996
Full chart Alerts Compare
Grade4.7
◀ Past 6.0● Present 4.6▶ Future 3.9
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

34 patents granted to the 7 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Armata Pharmaceuticals, Inc.’s names, not what it holds today.

Patents granted
34
34 utility, 1976 to Dec 31, 2025
Granted in 2025
3
Against none in 2024 and 1 in 2023
Applications published
30
1 of them in 2025
Names they are printed under
7
a former name, its own name, a subsidiary
By yearGrantedApplications published
'08'10'12'13'14'15'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals4
Medical technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name7 counted
Targeted Genetics Corporation a former name
US, as the owner printed on each patent
20 granted
5 published
Armata Pharmaceuticals, Inc. its own name
named as the applicant on its applications, in US
0 granted
15 published
BIOCONTROL LIMITED a subsidiary
GB, as the owner printed on each patent. 7 more under the same name are not counted (printed in US)
7 granted
4 published
ARMATA PHARMACEUTICALS, INC. its own name
US, as the owner printed on each patent
6 granted
0 published
BIOCONTROL LIMITED a subsidiary
named as the applicant on its applications, in GB. 1 more under the same name are not counted (printed in US)
0 granted
4 published
AmpliPhi Biosciences Corporation a former name
named as the applicant on its applications, in US
0 granted
2 published
Ampliphi Biosciences Corporation a former name
US, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 23, 202512,503,687Therapeutic bacteriophage compositionsPharmaceuticalsARMATA PHARMACEUTICALS, INC.
Apr 8, 202512,268,720Bacteriophage for treatment and prevention of E. coli and B. fragilis infectionsPharmaceuticalsARMATA PHARMACEUTICALS, INC.
Mar 4, 202512,239,677Therapeutic bacteriophage compositions for treating Staphylococcus infectionPharmaceuticalsARMATA PHARMACEUTICALS, INC.
May 23, 202311,654,166Therapeutic bacteriophage compositions for treating Staphylococcus infectionPharmaceuticalsARMATA PHARMACEUTICALS, INC.
Feb 22, 202211,253,557Therapeutic bacteriophage compositionsMedical technologyARMATA PHARMACEUTICALS, INC.
Dec 31, 201910,517,908Therapeutic bacteriophage compositionsMedical technologyARMATA PHARMACEUTICALS, INC.
Nov 13, 201810,124,027Therapeutic bacteriophage compositionsPharmaceuticalsBIOCONTROL LIMITED
Jun 27, 20179,687,514Bacteriophage-containing therapeutic agentsPharmaceuticalsBIOCONTROL LIMITED
Apr 18, 20179,623,058BacteriophagesPharmaceuticalsAmpliphi Biosciences Corporation
Jul 2, 20138,475,787Beneficial effects of bacteriophage treatmentsPharmaceuticalsBIOCONTROL LIMITED
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
May 29, 20252025/0170195BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTIONSPharmaceuticalsArmata Pharmaceuticals, Inc.
Oct 24, 20242024/0352428BACTERIOPHAGES WITH IMPROVED ANTIMICROBIAL ACTIVITYPharmaceuticalsArmata Pharmaceuticals, Inc.
Jul 11, 20242024/0226205BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTIONPharmaceuticalsArmata Pharmaceuticals, Inc.
Jun 13, 20242024/0189373BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTIONPharmaceuticalsArmata Pharmaceuticals, Inc.
Aug 31, 20232023/0272352THERAPEUTIC BACTERIOPHAGE COMPOSITIONSPharmaceuticalsArmata Pharmaceuticals, Inc. · patent 12,503,687 granted from it
Aug 10, 20232023/0248789THERAPEUTIC BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTIONPharmaceuticalsArmata Pharmaceuticals, Inc. · patent 12,239,677 granted from it
Jun 8, 20232023/0174954BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTIONPharmaceuticalsArmata Pharmaceuticals, Inc.
Mar 23, 20232023/0092021BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTIONPharmaceuticalsArmata Pharmaceuticals, Inc.
Dec 2, 20212021/0369798BACTERIOPHAGE FOR TREATMENT AND PREVENTION OF BACTERIA-ASSOCIATED CANCERSPharmaceuticalsArmata Pharmaceuticals, Inc. · patent 12,268,720 granted from it
Nov 25, 20212021/0361727BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTIONSPharmaceuticalsArmata Pharmaceuticals, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 4.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ARMP · research, not advice